CytoPherx raises $5M to develop dialysis filters

CytoPherx Inc. has raised $5 million of an anticipated $7.5 million Series B round to develop a device that filters the blood of kidney disease patients. The funding will go toward a clinical trial of the Ann Arbor, Mich. company’s hollow-fiber dialysis filters, which are used to isolate and deactivate white blood cells in a […]